Results 71 to 80 of about 2,519,772 (150)
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide and a major contributor to liver‐related morbidity and mortality. Its progressive subtype, metabolic dysfunction–associated steatohepatitis (MASH), is characterized by hepatocellular injury, inflammation,
Zubaier Ahmed +3 more
wiley +1 more source
Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases
In the past ten years, our understanding of the importance of bile acids has expanded from fat absorption and glucose/lipid/energy homeostasis into potential therapeutic targets for amelioration of chronic cholestatic liver diseases.
Vik Meadows +7 more
doaj +1 more source
Obeticholic acid for the treatment of primary biliary cirrhosis
Introduction: There is significant unmet need in Primary Biliary Cholangitis (PBC) in patients under-responsive to the only approved therapy Ursodeoxycholic Acid (UDCA) who are at increased risk of progressing to end-stage liver disease. Obeticholic Acid
Jones DEJ
core +4 more sources
Primary biliary cholangitis is a progressive disease with complications such as liver cirrhosis and hepatocellular carcinoma, and the treatment goal is to delay its progression.
Gi Eun Kim +3 more
doaj +1 more source
Multiple roles of bile acids in ferroptosis regulation: Opportunities for disease therapy
Bile acids (BAs), the main component of bile, play a key role in the digestion of lipids. However, recent studies have demonstrated that BAs can also act as signaling molecules, regulating metabolism by binding to BA receptors.
Nan Wu +4 more
doaj +1 more source
Introduction: Farnesoid X nuclear receptor is involved in the regulation of lipid and glucose metabolism, though mainly in the homeostasis of bile acids. Indeed, the agonists of farnesoid X nuclear receptor represent promising drugs.
Stefano Gitto +7 more
core +1 more source
Obeticholic acid for the treatment of primary biliary cirrhosis [PDF]
Primary biliary cirrhosis (PBC) is characterized by progressive nonsuppurative destruction of small bile ducts, resulting in intrahepatic cholestasis, fibrosis and ultimately end-stage liver disease.
Hirschfield, Gideon M +2 more
core +1 more source
Role of Farnesoid X Receptor Ligand Obeticholic Acid Versus Vitamin E for Patients with Nonalcoholic Steatohepatitis [PDF]
Background: Non-alcoholic fatty liver disease (NAFLD) is a leading metabolic disorder that commonly progresses to non-alcoholic steatohepatitis (NASH), potentially complicated with cirrhosis, liver failure, and hepatocellular carcinoma.Aim: To compare ...
doaj +1 more source
9 p.Background & aims: In advanced cirrhosis, gut bacterial translocation is the consequence of intestinal barrier disruption and leads to bacterial infection.
Pastor Rojo, Óscar +12 more
core +1 more source
Supplemental material, Supplementary_Material for Synthesis and characterization of new impurities in obeticholic acid by Wei-Dong Feng, Song-Ming Zhuo and Fu-Li Zhang in Journal of Chemical ...
Wei-Dong Feng (5635334) +2 more
core +1 more source

